Author

Mark T. Kershaw

Observed names: Mark Kershaw, Mark T Kershaw

Institution: Forma Therapeutics (United States)

Observed institution: Forma Therapeutics (United States)

OpenAlex ID: A5004289818

Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor

2020 · Justin A. Caravella, Jian Lin, et al. · Journal of Medicinal Chemistry · 162

Synthesis of 2-Aryl-oxazolo[4,5-c]quinoline-4(5H)-ones and 2-Aryl-thiazolo[4,5-c]quinoline-4(5H)-ones

2003 · Kevin J. Hodgetts, Mark T. Kershaw · Organic Letters · 67

Ethyl 2-Chlorooxazole-4-carboxylate: A Versatile Intermediate for the Synthesis of Substituted Oxazoles

2002 · Kevin J. Hodgetts, Mark T. Kershaw · Organic Letters · 64

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors

2019 · Jian Lin, Wei Lu, et al. · Journal of Medicinal Chemistry · 51

Regiocontrolled Synthesis of Substituted Thiazoles

2002 · Kevin J. Hodgetts, Mark T. Kershaw · Organic Letters · 50

Discovery of Novel 6,6-Heterocycles as Transient Receptor Potential Vanilloid (TRPV1) Antagonists

2010 · Charles A. Blum, Timothy Caldwell, et al. · Journal of Medicinal Chemistry · 37

The design, synthesis and structure–activity relationships of 1-aryl-4-aminoalkylisoquinolines: A novel series of CRF-1 receptor antagonists

2008 · Taeyoung Yoon, Stéphane De Lombaert, et al. · Bioorganic & Medicinal Chemistry Letters · 22

Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN)

2019 · Matthew W. Martin, David R. Lancia, et al. · Bioorganic & Medicinal Chemistry Letters · 21

Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution

2008 · Charles A. Blum, Xiaozhang Zheng, et al. · Bioorganic & Medicinal Chemistry Letters · 18

FT-1101: A Structurally Distinct Pan-BET Bromodomain Inhibitor with Activity in Preclinical Models of Hematologic Malignancies

2015 · David S Millan, Monica A Alvarez Morales, et al. · Blood · 15

1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists

2008 · Qin Guo, Jayaraman Chandrasekhar, et al. · Bioorganic & Medicinal Chemistry Letters · 11

Aminopyrazine CB1 receptor inverse agonists

2008 · David J. Wustrow, George D. Maynard, et al. · Bioorganic & Medicinal Chemistry Letters · 8

Advancing Parallel Solution Phase Library Synthesis through Efficient Purification, Quantitation, and Characterization Techniques

2003 · Jeffrey W. Noonan, Joe N. Brown, et al. · JALA Journal of the Association for Laboratory Automation · 5

Synthesis of 2‐Aryl‐oxazolo[4,5‐c]quinoline‐4(5H)‐ones and 2‐Aryl‐thiazolo[4,5‐c]quinoline‐4(5H)‐ones.

2003 · Kevin J. Hodgetts, Mark T. Kershaw · ChemInform

Ethyl 2‐Chlorooxazole‐4‐carboxylate: A Versatile Intermediate for the Synthesis of Substituted Oxazoles.

2002 · Kevin J. Hodgetts, Mark T. Kershaw · ChemInform

ChemInform Abstract: Regiocontrolled Synthesis of Substituted Thiazoles.

2002 · Kevin J. Hodgetts, Mark T. Kershaw · ChemInform

Works count: 16

Citation count: 531

H-index: 11

I10-index: 11